Descriptive et Topographique. 6ème édition, pp.1018-1022, 1948. ,
The prostate gland in old age, Ann Surg. déc, vol.62, issue.6, pp.716-753, 1915. ,
The zonal anatomy of the prostate. The Prostate, vol.2, pp.35-49, 1981. ,
, , 1953.
Embryologie médicale. 13ème. Pradel ,
Projection de l'incidence et de la mortalité par cancer en France métropolitaine en 2017. Rapport technique, vol.53, 2017. ,
,
, Progres En Urol J Assoc Francaise Urol Soc Francaise Urol, vol.27, issue.1, pp.95-143, 2016.
Le cancer de la prostate : incidence, survie et mortalité en France, Bull Epidémiol Hebd, pp.693-702, 2016. ,
Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up, J Natl Cancer Inst, vol.104, issue.2, pp.125-157, 2012. ,
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up, Lancet Lond Engl. 6 déc, vol.384, issue.9959, pp.2027-2062, 2014. ,
Mortality results from the Göteborg randomised population-based prostate-cancer screening trial, Lancet Oncol. août, vol.11, issue.8, pp.725-757, 2010. ,
Purification of a human prostate specific antigen, Invest Urol. sept, vol.17, issue.2, pp.159-63, 1979. ,
,
, Progres En Urol J Assoc Francaise Urol Soc Francaise Urol. janv, vol.21, issue.1, pp.18-28, 2011.
Biopsie prostatique : techniques et indications, Techniques chirurgicales -Urologie, pp.41-265, 2010. ,
Re-biopsy of the prostate using a stereotactic transperineal technique, J Urol, vol.176, issue.4, pp.1376-81, 2006. ,
Comparison between transrectal and transperineal prostate biopsy for detection of prostate cancer: a meta-analysis and trial sequential analysis, Oncotarget. 4 avr, vol.8, issue.14, pp.23322-23358, 2017. ,
Classification of prostatic carcinomas, Cancer Chemother Rep. mars, vol.50, issue.3, pp.125-133, 1966. ,
Gleason's score: update in, 2008. ,
, Ann Pathol, vol.28, issue.5, pp.350-353, 2008.
Synthèse des guidelines de l'EAU face aux particularités francaises. Cancer de prostate ,
ISUP Grading Committee, The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma, vol.29, pp.1228-1270, 2005. ,
Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System, International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of, vol.40, pp.244-52, 2014. ,
UICC International Union Against Cancer, pp.243-248, 2009. ,
Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer, JAMA. 16 sept, vol.280, issue.11, pp.969-74, 1998. ,
Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate, J Urol. juill, vol.142, issue.1, pp.71-75, 1989. ,
Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer, J Urol. févr, vol.159, issue.2, pp.475-476, 1998. ,
Extensive biopsy protocol improves the detection rate of prostate cancer, J Urol. août, vol.164, issue.2, pp.393-399, 2000. ,
The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer, Urology, vol.50, issue.4, pp.562-568, 1997. ,
Pain and morbidity of an extensive prostate 10-biopsy protocol: a prospective study in 289 patients, J Urol. janv, vol.167, issue.1, pp.218-239, 2002. ,
Random biopsy: when, how many and where to take the cores?, World J Urol. août, vol.32, issue.4, pp.859-69, 2014. ,
Prospective evaluation of a 21-sample needle biopsy procedure designed to improve the prostate cancer detection rate, Urology. juin, vol.61, issue.6, pp.1181-1187, 2003. ,
Prostate saturation biopsy in the reevaluation of microfocal prostate cancer, J Urol. sept, vol.176, issue.3, pp.963-964, 2006. ,
Saturation biopsies on autopsied prostates for detecting and characterizing prostate cancer, BJU Int. janv, vol.103, issue.1, pp.49-54, 2009. ,
Saturation prostate needle biopsy and prostate cancer detection at initial and repeat evaluation, Urology. déc, vol.70, issue.6, pp.1131-1136, 2007. ,
Extended biopsy protocol decreases prostate cancer incidence and risk of aggressive disease on repeated biopsies compared with initial standard procedure, Urol Int, vol.84, issue.2, pp.147-52, 2010. ,
Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy, Eur Urol. mars, vol.55, issue.3, pp.600-606, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00300206
Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patients, Eur Urol. août, vol.52, issue.2, pp.430-435, 2007. ,
Prospective evaluation of an extended 21-core biopsy scheme as initial prostate cancer diagnostic strategy, Eur Urol. janv, vol.65, issue.1, pp.154-61, 2014. ,
Extended sampling at first biopsy improves cancer detection rate: results of a prospective, randomized trial comparing 12 versus 18-core prostate biopsy, J Urol. juin, vol.185, issue.6, pp.2132-2138, 2011. ,
Is an initial saturation prostate biopsy scheme better than an extended scheme for detection of prostate cancer? A systematic review and meta-analysis, Eur Urol. juin, vol.63, issue.6, pp.1031-1040, 2013. ,
Is an extended 20-core prostate biopsy protocol more efficient than the standard 12-core? A randomized multicenter trial, J Urol. juill, vol.190, issue.1, pp.77-83, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01718067
Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review, J Urol. mai, vol.175, issue.5, pp.1605-1617, 2006. ,
Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds, J Urol, vol.186, issue.5, pp.1818-1842, 2011. ,
Multifocality and prostate cancer detection by multiparametric magnetic resonance imaging: correlation with wholemount histopathology, Eur Urol. mars, vol.67, issue.3, pp.569-76, 2015. ,
Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: a prospective study, Eur Radiol. juill, vol.23, issue.7, pp.2019-2048, 2013. ,
Prostate cancer: incremental value of endorectal MR imaging findings for prediction of extracapsular extension, Radiology. juill, vol.232, issue.1, pp.133-142, 2004. ,
Endorectal magnetic resonance imaging as a predictor of biochemical outcome after radical prostatectomy in men with clinically localized prostate cancer, J Urol. sept, vol.164, issue.3, pp.759-63, 2000. ,
Patient selection for magnetic resonance imaging of prostate cancer, Eur Urol. sept, vol.40, issue.3, pp.300-307, 2001. ,
Wiegel T.; members of the EAU -ESTRO -ESUR -SIOG Prostate Cancer Guidelines Panel. EAU -ESTRO -ESUR -SIOG Guidelines on Prostate Cancer. Edn. presented at the EAU Annual Congress Copenhagen, 2018. ,
Comparison of image-guided targeted biopsies versus systematic randomized biopsies in the detection of prostate cancer: a systematic literature review of well-designed studies, World J Urol. août, vol.32, issue.4, pp.847-58, 2014. ,
Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis, Eur Urol. sept, vol.68, issue.3, pp.438-50, 2015. ,
A Randomized Controlled Trial To Assess and Compare the Outcomes of Two-core Prostate Biopsy Guided by Fused Magnetic Resonance and Transrectal Ultrasound Images and Traditional 12-core Systematic Biopsy, Eur Urol. janv, vol.69, issue.1, pp.149-56, 2016. ,
,
, Progres En Urol J Assoc Francaise Urol Soc Francaise Urol. déc, vol.27, issue.16, pp.1023-1053, 2017.
Magnetic resonance imaging does not improve the prediction of misclassification of prostate cancer patients eligible for active surveillance when the most stringent selection criteria are based on the saturation biopsy scheme, BJU Int. août, vol.108, issue.4, pp.513-520, 2011. ,
Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer, J Clin Oncol Off J Am Soc Clin Oncol. 1 janv, vol.28, issue.1, pp.126-157, 2010. ,
Long-term Results of Active Surveillance in the Göteborg Randomized, Population-based Prostate Cancer Screening Trial, Eur Urol, vol.70, issue.5, pp.760-766, 2016. ,
Active surveillance for the management of prostate cancer in a contemporary cohort, Cancer. 15 juin, vol.112, issue.12, pp.2664-70, 2008. ,
A single centre experience of active surveillance as management strategy for low-risk prostate cancer in Ireland, Ir J Med Sci. sept, vol.183, issue.3, pp.377-82, 2014. ,
Careful selection and close monitoring of low-risk prostate cancer patients on active surveillance minimizes the need for treatment, Eur Urol. déc, vol.58, issue.6, pp.831-836, 2010. ,
Medium-term outcomes of active surveillance for localised prostate cancer, Eur Urol. déc, vol.64, issue.6, pp.981-988, 2013. ,
Pathological findings after radical prostatectomy in men eligible for active surveillance ,
URL : https://hal.archives-ouvertes.fr/inserm-00453763
, Progres En Urol J Assoc Francaise Urol Soc Francaise Urol. avr, vol.21, issue.4, pp.264-273, 2011.
Active surveillance for low-risk prostate cancer worldwide: the PRIAS study, Eur Urol. avr, vol.63, issue.4, pp.597-603, 2013. ,
Active surveillance program for prostate cancer: an update of the Johns Hopkins experience, J Clin Oncol Off J Am Soc Clin Oncol. 1 juin, vol.29, issue.16, pp.2185-90, 2011. ,
Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement, J Clin Oncol Off J Am Soc Clin Oncol, vol.20, issue.18, pp.2182-90, 2016. ,
Clinical utility of total length Gleason pattern 4 on biopsy in men with Grade Group 2 prostate cancer, J Urol. 1 août, 2018. ,
Active Surveillance for Intermediate Risk Prostate Cancer: Survival Outcomes in the Sunnybrook Experience, J Urol. déc, vol.196, issue.6, pp.1651-1659, 2016. ,
Saturation technique does not improve cancer detection as an initial prostate biopsy strategy, J Urol. févr, vol.175, issue.2, pp.485-493, 2006. ,
Using a saturation biopsy scheme increases cancer detection during repeat biopsy in men with high-grade prostatic intraepithelial neoplasia, Urology, vol.78, issue.5, pp.1115-1124, 2011. ,
Should follow-up biopsies for men on active surveillance for prostate cancer be restricted to limited templates?, Urology. août, vol.82, issue.2, pp.405-414, 2013. ,
Prostate-specific antigen kinetics during follow-up are an unreliable trigger for intervention in a prostate cancer surveillance program, J Clin Oncol Off J Am Soc Clin Oncol. 10 juin, vol.28, issue.17, pp.2810-2816, 2010. ,
Radical prostatectomy versus observation for localized prostate cancer, N Engl J Med, vol.367, issue.3, pp.203-216, 2012. ,
Radical prostatectomy or watchful waiting in early prostate cancer, N Engl J Med. 6 mars, vol.370, issue.10, pp.932-974, 2014. ,
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer, N Engl J Med, vol.375, issue.15, pp.1415-1439, 2016. ,
Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium, Urology. déc, vol.58, issue.6, pp.843-851, 2001. ,
Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update, JAMA. 14 mai, vol.277, issue.18, pp.1445-51, 1997. ,
Comparison of nomograms predicting lymph node invasion in patients undergoing radical prostatectomy for prostate cancer, Ir J Med Sci. févr, vol.187, issue.1, pp.33-40, 2018. ,
Population-Based External Validation of the Updated 2012 Partin Tables in Contemporary North American Prostate Cancer Patients. The Prostate, vol.77, pp.105-118, 2017. ,
The CAPRA-S score: A straightforward tool for improved prediction of outcomes after radical prostatectomy, Cancer, vol.15, issue.22, pp.5039-5085, 2011. ,
MRI in active surveillance: a critical review, Prostate Cancer Prostatic Dis. 16 août, 2018. ,
Role of MRI in low-risk prostate cancer: finding the wolf in sheep's clothing or the sheep in wolf's clothing?, Curr Opin Urol. mai, vol.27, issue.3, pp.238-283, 2017. ,
Relationship between non-suspicious MRI and insignificant prostate cancer: results from a monocentric study, World J Urol. mai, vol.34, issue.5, pp.673-681, 2016. ,
Reclassification Rates of Patients Eligible for Active Surveillance After the Addition of Magnetic Resonance Imaging-Ultrasound Fusion Biopsy: An Analysis of 7 Widely Used Eligibility Criteria, Urology. déc, vol.110, pp.134-143, 2017. ,
A prospective comparison of MRI-US fused targeted biopsy versus systematic ultrasound-guided biopsy for detecting clinically significant prostate cancer in patients on active surveillance, J Magn Reson Imaging JMRI. janv, vol.41, issue.1, pp.220-225, 2015. ,
Value of 3-Tesla multiparametric magnetic resonance imaging and targeted biopsy for improved risk stratification in patients considered for active surveillance, BJU Int, vol.119, issue.4, pp.535-577, 2017. ,
Positive pre-biopsy MRI: are systematic biopsies still useful in addition to targeted biopsies?, World J Urol. 2 juill, 2018. ,
Predicting Gleason Group Progression for Men on Prostate Cancer Active Surveillance: The Role of a Negative Confirmatory MRI-US Fusion Biopsy, J Urol. 28 juill, 2018. ,
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study, Lancet Lond Engl, vol.25, pp.815-837, 2017. ,
Magnetic resonance imaging in active surveillance of prostate cancer: a systematic review, Eur Urol. avr, vol.67, issue.4, pp.627-663, 2015. ,
Predicting high-grade cancer at ten-core prostate biopsy using four kallikrein markers measured in blood in the ProtecT study, J Natl Cancer Inst. juill, issue.7, p.107, 2015. ,
Clinical evaluation of the PCA3 assay in guiding initial biopsy decisions, J Urol. juin, vol.185, issue.6, pp.2119-2144, 2011. ,
Can urinary PCA3 supplement PSA in the early detection of prostate cancer?, J Clin Oncol Off J Am Soc Clin Oncol. 20 déc, vol.32, issue.36, pp.4066-72, 2014. ,
Prostate cancer antigen 3 score accurately predicts tumour volume and might help in selecting prostate cancer patients for active surveillance, Eur Urol. mars, vol.59, issue.3, pp.422-431, 2011. ,
Accuracy of PCA3 measurement in predicting short-term biopsy progression in an active surveillance program, J Urol. févr, vol.183, issue.2, pp.534-542, 2010. ,
Longitudinal assessment of urinary PCA3 for predicting prostate cancer grade reclassification in favorable-risk men during active surveillance, Prostate Cancer Prostatic Dis, vol.20, issue.3, pp.339-381, 2017. ,
Urinary TMPRSS2:ERG and PCA3 in an active surveillance cohort: results from a baseline analysis in the Canary Prostate Active Surveillance Study, Clin Cancer Res Off J Am Assoc Cancer Res. 1 mai, vol.19, issue.9, pp.2442-50, 2013. ,
Prognostic value of urinary prostate cancer antigen 3 (PCA3) during active surveillance of patients with low-risk prostate cancer receiving 5?-reductase inhibitors, BJU Int, vol.121, issue.3, pp.399-404, 2018. ,
Prognostic Biomarkers Used for Localised Prostate Cancer Management: A Systematic Review, Eur Urol Focus. 7 mars, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-02355786
,
, Progres En Urol J Assoc Francaise Urol Soc Francaise Urol. janv, vol.25, issue.1, pp.1-10, 2015.
Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer, Cancer. 1 févr, vol.71, issue.3, pp.933-941, 1993. ,
Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer, JAMA. 2 févr, vol.271, issue.5, pp.368-74, 1994. ,
The contemporary concept of significant versus insignificant prostate cancer, Eur Urol. août, vol.60, issue.2, pp.291-303, 2011. ,
Characteristics of insignificant clinical T1c prostate tumors. A contemporary analysis. Cancer, vol.101, pp.2001-2006, 2004. ,
Incidence of Extraprostatic Extension at Radical Prostatectomy with Pure Gleason Score 3 + 3 = 6 (Grade Group 1) Cancer: Implications for Whether Gleason Score 6 Prostate Cancer Should be Renamed « Not Cancer » and for Selection Criteria for Active Surveillance, J Urol. juin, vol.199, issue.6, pp.1482-1489, 2018. ,
Definition of Insignificant Tumor Volume of Gleason Score 3 + 3 = 6 (Grade Group 1) Prostate Cancer at Radical Prostatectomy-Is it Time to Increase the Threshold?, J Urol. déc, vol.196, issue.6, pp.1664-1673, 2016. ,
Does mpMRI improve clinical criteria in selecting men with prostate cancer for active surveillance? Prostate Cancer Prostatic Dis, vol.20, pp.323-330, 2017. ,
Magnetic resonance imaging for predicting prostate biopsy findings in patients considered for active surveillance of clinically low risk prostate cancer, J Urol, vol.188, issue.5, pp.1732-1740, 2012. ,
Dynamic contrastenhanced-magnetic resonance imaging evaluation of intraprostatic prostate cancer: correlation with radical prostatectomy specimens, Urology, vol.74, issue.5, pp.1094-1103, 2009. ,
Place de la surveillance active dans le cancer de la prostate: présentation du protocole français, Prog En Urol, vol.18, issue.4, pp.12-18, 2008. ,
Biopsy schemes with the fewest cores for detecting 95% of the prostate cancers detected by a 24-core biopsy, Eur Urol. janv, vol.57, issue.1, pp.1-8, 2010. ,
,
, Progres En Urol J Assoc Francaise Urol Soc Francaise Urol. janv, vol.27, issue.1, pp.38-45, 2017.
Performance of biopsy factors in predicting unfavorable disease in patients eligible for active surveillance according to the PRIAS criteria, Prostate Cancer Prostatic Dis. déc, vol.18, issue.4, pp.338-380, 2015. ,
Predictive Factors for Reclassification and Relapse in Prostate Cancer Eligible for Active Surveillance: A Systematic Review and Meta-analysis, Urology, vol.91, pp.136-178, 2016. ,
External validation of Chun, PCPT, ERSPC, Kawakami, and Karakiewicz nomograms in the prediction of prostate cancer: A single center cohort-study, Urol Oncol. août, vol.36, issue.8, pp.364-365, 2018. ,
Nomograms in urologic oncology, advantages and disadvantages, Curr Opin Urol. 7 août, 2018. ,
Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebocontrolled trial, Lancet Lond Engl. 24 mars, vol.379, issue.9821, pp.1103-1114, 2012. ,